• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Intellia Therapeutics, Inc. - Common Stock (NQ:NTLA)

    13.44 +0.29 (+2.21%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 3,322,919
    Open 12.73
    Bid (Size) 13.04 (200)
    Ask (Size) 13.46 (200)
    Prev. Close 13.15
    Today's Range 12.55 - 13.54
    52wk Range 5.900 - 28.25
    Shares Outstanding 88,140,978
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    The growth investor kicked off this week by buying up some hard-hit stocks. 
    Via The Motley Fool
    News headline image
    Investors Eye Explosive Growth in Anti-Aging Therapies as Market Targets $420B Milestone
    EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:GERN),(NASDAQ:NTLA),(NASDAQ:NAGE),(NASDAQ:OCGN) EQNX::TICKER_END 
    Via FinancialNewsMedia

    Performance

    YTD
    +45.9%
    +45.9%
    1 Month
    +8.7%
    +8.7%
    3 Month
    +39.9%
    +39.9%
    6 Month
    +11.4%
    +11.4%
    1 Year
    +35.8%
    +35.8%

    More News

    Read More
    News headline image
    Why Did NTLA Stock Jump 10% In Pre-Market Today? ↗
    Via Stocktwits
    News headline image
    Intellia (NTLA) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    Intellia Therapeutics Inc (NASDAQ:NTLA) Reports Strong Q4 2025 Revenue Beat and Confirms Key 2026 Pipeline Milestones ↗
    Via Chartmill
    News headline image
    This Cathie Wood Stock Is Already Up 41% This Year, But Is It a Buy? ↗
    Via The Motley Fool
    News headline image
    NTLA Stock Jumped 13% Today – What Is The Latest FDA Action All About? ↗
    Via Stocktwits
    Nasdaq, S&P 500 Futures Edge Higher Ahead Of Long Weekend: Why NVDA, MU, NTLA, ASTS Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Stocks
    News headline image
    Cathie Wood’s ARK Made Just One Buy Last Session — And It’s A Biotech Stock Up Nearly 30% YTD ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs
    News headline image
    Intellia CEO Sells $314K in Stock While Holding Over 1 Million Shares ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
    Via MarketMinute
    Topics Artificial Intelligence ETFs Economy
    News headline image
    2 Beaten-Down Stocks That Will Soar in 2026, According to Wall Street ↗
    Via The Motley Fool
    Topics Death
    News headline image
    How BridgeBio, A Top 4% Stock, Is Lining Up Dominos On Its Triple-Digit Sprint ↗
    Via Investor's Business Daily
    News headline image
    Intellia (NTLA) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    Via FinancialNewsMedia
    News headline image
    Longevity-Focused Health Fueling U.S. Anti-Aging Products Market Projected to Reach $27 Billion By 2033
    From MarketNewsUpdates.com
    Via GlobeNewswire
    News headline image
    2 Beaten-Down Stocks to Avoid Right Now ↗
    Via The Motley Fool
    Topics Death
    News headline image
    This Bath & Body Works Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗
    Via Benzinga
    News headline image
    This SPS Commerce Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗
    Via Benzinga
    News headline image
    What 21 Analyst Ratings Have To Say About Intellia Therapeutics ↗
    Via Benzinga
    News headline image
    Why Gene-Editing Giants Crispr And Intellia Just Surged ↗
    Via Investor's Business Daily
    Topics Death
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Intellia Therapeutics Crashes After A Patient In Its Pivotal Study Dies ↗
    Via Investor's Business Daily
    Topics Death
    News headline image
    2 Small-Cap Stocks With Far More Upside Than Any "Magnificent Seven" Stock, According to Wall Street ↗
    Via The Motley Fool
    News headline image
    Discover the top movers in Friday's pre-market session. ↗
    Via Chartmill

    Frequently Asked Questions

    Is Intellia Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Intellia Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Intellia Therapeutics, Inc. - Common Stock trade on?
    Intellia Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Intellia Therapeutics, Inc. - Common Stock?
    The ticker symbol for Intellia Therapeutics, Inc. - Common Stock is NTLA on the Nasdaq Stock Market
    What is the current price of Intellia Therapeutics, Inc. - Common Stock?
    The current price of Intellia Therapeutics, Inc. - Common Stock is 13.44
    When was Intellia Therapeutics, Inc. - Common Stock last traded?
    The last trade of Intellia Therapeutics, Inc. - Common Stock was at 03/06/26 04:00 PM ET
    What is the market capitalization of Intellia Therapeutics, Inc. - Common Stock?
    The market capitalization of Intellia Therapeutics, Inc. - Common Stock is 1.18B
    How many shares of Intellia Therapeutics, Inc. - Common Stock are outstanding?
    Intellia Therapeutics, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.